Präventionsstudie Antivirale Aktion gegen Autoimmunität bei Typ-1-Diabetes

This procedure is a written parliamentary question regarding a prevention study focused on using antiviral actions to combat autoimmunity in Type 1 diabetes. It seeks to clarify the status, goals, or findings of research aimed at preventing the onset of this autoimmune condition. This primarily affects medical researchers, healthcare providers, and individuals at risk of developing Type 1 diabetes.